Ecdysterone (20-Hydroxyecdysone)

Overview

Ecdysterone, also known as 20-hydroxyecdysone (20E), is the most abundant and biologically active ecdysteroid found in both insects, where it regulates molting and metamorphosis, and in numerous plant species, where it serves as a defense mechanism against herbivorous insects. Rich dietary sources include spinach, quinoa, and various adaptogenic herbs such as Rhaponticum carthamoides (maral root) and Cyanotis vaga. Its structural similarity to testosterone initially sparked interest in its potential anabolic properties.

Research into ecdysterone's effects on mammalian muscle tissue has produced intriguing results. Studies suggest that ecdysterone may enhance muscle protein synthesis through a mechanism involving the estrogen receptor beta (ERbeta) rather than the androgen receptor, which distinguishes it from anabolic-androgenic steroids. A notable 2019 study from Freie Universitat Berlin reported significant increases in muscle mass and bench press strength in resistance-trained men supplemented with ecdysterone compared to placebo, prompting the World Anti-Doping Agency (WADA) to investigate its potential inclusion on the prohibited substance list.

Despite the growing body of research, ecdysterone's efficacy remains debated. Supplemental doses used in studies range from 200 to 800 mg per day, though bioavailability is a concern as the compound undergoes extensive first-pass metabolism. Ecdysterone is currently legal and available as a dietary supplement in most countries. It does not appear to affect testosterone, estrogen, or cortisol levels in humans, making it an attractive option for those seeking natural performance support without hormonal disruption, though more large-scale clinical trials are needed to confirm its benefits.

Mechanism of Action

"

Non-Hormonal Anabolic Signaling via Estrogen Receptor Beta\n\nEcdysterone (20-hydroxyecdysone, 20E) is a polyhydroxylated sterol and the principal bioactive ecdysteroid in arthropods, also found in plants (Rhaponticum carthamoides, spinach, quinoa) as a phytoecdysteroid. Despite structural similarity to steroid hormones, ecdysterone does not bind androgen receptors (AR) or glucocorticoid receptors (GR). Instead, its anabolic effects in mammals are mediated through estrogen receptor beta (ERbeta) activation, specifically the ERbeta membrane-associated signaling complex. ERbeta engagement triggers rapid non-genomic activation of PI3K/Akt and MAPK/ERK1/2 pathways, stimulating mTORC1-dependent protein synthesis via phosphorylation of p70S6K1 and 4E-BP1 in skeletal muscle fibers (PMID: 31123801).\n\n

Muscle Protein Synthesis and Myogenic Differentiation\n\nIn C2C12 myotubes and primary human skeletal muscle cells, ecdysterone (1–10 microM) increases myofibrillar protein synthesis by 20% through Akt-mediated phosphorylation of the FoxO3a transcription factor, sequestering it in the cytoplasm and preventing expression of muscle-specific E3 ubiquitin ligases MuRF1 (TRIM63) and atrogin-1 (MAFbx/FBXO32) — the primary drivers of muscle proteolysis. Ecdysterone also promotes satellite cell activation by upregulating MyoD and myogenin transcription factors, enhancing myoblast proliferation and differentiation. A controlled human trial (200 mg/day for 10 weeks) showed significant increases in one-repetition maximum bench press performance compared to placebo, without alterations in urinary steroid profiles (PMID: 31123801).\n\n

Hepatoprotective and Metabolic Actions\n\nEcdysterone activates hepatic AMPK through upstream LKB1 phosphorylation, inhibiting acetyl-CoA carboxylase (ACC) and HMG-CoA reductase (HMGCR), thereby reducing de novo lipogenesis and cholesterol synthesis. It enhances insulin sensitivity by increasing GLUT4 translocation in adipocytes and muscle through Akt/AS160 signaling. Additionally, ecdysterone exhibits hepatoprotective effects by upregulating Nrf2-ARE antioxidant defense genes (HO-1, NQO1, glutathione S-transferase) and reducing CCl4-induced hepatic fibrosis markers in preclinical models (PMID: 25009044)."

Reconstitution Calculator

Research

Safety Profile

Common Side Effects

• Generally considered very well-tolerated with a strong safety profile at doses up to 500 mg/day
• Mild gastrointestinal symptoms including stomach discomfort, nausea, or diarrhea reported infrequently
• Occasional reports of mild headache or dizziness
• Some users report increased appetite, which is expected given its proposed mechanism of action on protein synthesis

Serious Adverse Effects

• No serious adverse effects have been documented in human clinical trials
• Long-term safety data beyond 12 weeks of continuous supplementation is limited
• Despite structural similarity to insect molting hormones, ecdysterone does not bind human androgen receptors and has not demonstrated androgenic or estrogenic activity in human studies
• No liver toxicity has been observed at standard supplemental doses, unlike synthetic anabolic agents

Contraindications

• Individuals with known allergies to spinach or quinoa (common dietary sources) should exercise caution
• Pregnant and breastfeeding women should avoid supplementation due to insufficient safety data in these populations
• Children and adolescents should not supplement with ecdysterone without medical supervision
• Those with hormone-sensitive conditions should consult a healthcare provider, despite the lack of demonstrated hormonal activity in humans

Drug Interactions

• Limited data on drug interactions; no clinically significant interactions have been identified to date
• Theoretical concern with concurrent use of anabolic or performance-enhancing substances due to overlapping targets in protein synthesis pathways
• May theoretically interact with medications metabolized by hepatic enzymes, though specific cytochrome P450 interactions have not been characterized
• Individuals on glucose-lowering medications should monitor blood sugar, as some animal studies suggest mild hypoglycemic effects

Population-Specific Considerations

• Athletes should be aware that ecdysterone has been discussed by WADA for potential inclusion on the prohibited list; verify current regulatory status
• Older adults may benefit from starting at lower doses (200 mg/day) and titrating upward
• The compound has been studied in Russian and Eastern European clinical contexts for decades without notable safety signals

Pharmacokinetic Profile